Search clinical trials for: Elotuzumab (HuLuc63)
Total 160 results
-
AbbottBristol-Myers SquibbTerminated
-
Bristol-Myers SquibbAbbVieCompletedSmoldering Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterRecruitingPrimary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Myelofibrosis Transformation in Essential ThrombocythemiaUnited States
-
Facet BiotechCompletedMultiple MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
Bristol-Myers SquibbCompleted
-
AbbVie (prior sponsor, Abbott)Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbAbbVieCompletedLymphoma | Multiple MyelomaUnited States, Belgium, France, Germany, Italy, Japan, United Kingdom, Australia, Poland, Puerto Rico, Canada, Denmark, Hungary, Israel, Spain, Czechia, Ireland, Austria, Switzerland, Greece, Turkey, Romania, United Arab Emirates
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Celgene; The Leukemia and Lymphoma Society; Multiple Myeloma... and other collaboratorsCompletedSmoldering Multiple Myeloma | Smoldering MyelomaUnited States
-
Bristol-Myers SquibbAbbVieCompleted
-
Yale UniversityGlaxoSmithKlineRecruitingMultiple MyelomaUnited States
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Germany, Greece, Hungary, Ireland, Israel, Italy, Poland, Puerto Rico, Romania, Russian Federation, Spain, Switzerland, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCCompletedAdvanced Solid Tumors
-
Merck Sharp & Dohme LLCAriad PharmaceuticalsCompleted
-
Merck Sharp & Dohme LLCCompletedMultiple Myeloma | Solid Tumor
-
Merck Sharp & Dohme LLCCompleted
-
Gilead SciencesCompletedLymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Non-Hodgkin | Lymphoma, Low-Grade | Lymphoma, Small Lymphocytic | Leukemia, Prolymphocytic | NHL | CLL | Leukemia, Lymphocytic, Chronic | Lymphoma, Intermediate-Grade | Lymphoma, Large-Cell | Lymphoma, Mixed-Cell | Lymphoma, Small-Cell | Leukemia, B-Cell, Chronic | Leukemia... and other conditionsUnited States
-
Gilead SciencesCompletedNon-Hodgkin's Lymphoma | Lymphoma, Diffuse | Lymphoma, Diffuse, Mixed Lymphocytic-HistiocyticFrance, United Kingdom
-
Gilead SciencesTerminatedPurpura, Thrombocytopenic, Idiopathic | Autoimmune Thrombocytopenic Purpura | Purpura, Thrombocytopenic, AutoimmuneUnited States
-
Novartis PharmaceuticalsWithdrawn
-
PfizerUCB PharmaCompletedLymphomaUnited States, Belgium, Japan, Korea, Republic of, Germany, Hong Kong, Hungary, Netherlands, Singapore
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States
-
University of Wisconsin, MadisonRadius Health, Inc.Active, not recruitingOsteoporosis | Arthroplasties, Knee ReplacementUnited States
-
Nicola GoekbugetRecruitingPrecursor Cell Lymphoblastic LeukemiaGermany
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Radius Health, Inc.Completed
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingAcute Lymphoid LeukemiaItaly
-
PfizerCompletedLymphoma, B-CellUnited States, Spain, France, Switzerland, United Kingdom, Belgium, Germany
-
Institute of Hematology & Blood Diseases HospitalNot yet recruiting
-
Wake Forest University Health SciencesBristol-Myers Squibb; Atrium Health Levine Cancer InstituteActive, not recruitingMultiple MyelomaUnited States
-
Bristol-Myers SquibbNo longer availableMultiple Myeloma
-
Anklam ExtraktBioTeSys GmbHCompleted
-
PfizerCompletedLeukemia | Precursor b-Cell Lymphoblastic Leukemia-Lymphoma | ACUTE LYMPHOBLASTIC LEUKEMIAUnited States, Spain, Taiwan, Singapore, India, Hungary, Turkey, Poland
-
Bristol-Myers SquibbCompleted
-
Queen Mary University of LondonGilead SciencesUnknownRecurrent or Refractory B Cell Acute Lymphoblastic LeukaemiaUnited Kingdom
-
Tulane University School of MedicineKaryopharm Therapeutics IncWithdrawnRefractory Multiple Myeloma | Relapsed Multiple Myeloma
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbTerminatedMultiple MyelomaUnited States
-
Gilead SciencesCompletedNon-Hodgkin's LymphomaUnited States
-
Merck Sharp & Dohme LLCTerminated
-
Assistance Publique - Hôpitaux de ParisWithdrawn
-
PfizerActive, not recruiting
-
Versailles HospitalActive, not recruitingAcute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP)France
-
Institute of Hematology & Blood Diseases HospitalNot yet recruitingMinimal Residual Disease | Bone Marrow Transplant | Ph+ ALLChina
-
Medical College of WisconsinRecruitingMultiple MyelomaUnited States
-
Beth ChristianGilead SciencesCompleted
-
PfizerActive, not recruitingAcute Lymphoblastic LeukemiaChina
-
PfizerUCB PharmaCompletedB-Cell LymphomaUnited States, Belgium, Korea, Republic of, Switzerland, France, Poland, Spain, Hong Kong, Australia, Germany, Italy, Netherlands, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
PfizerCompleted
-
Bristol-Myers SquibbNot yet recruitingRelapsed or Refractory Multiple MyelomaTaiwan